Stockwell Lynn 4
4 · Drugs Made In America Acquisition Corp. · Filed Feb 18, 2025
Insider Transaction Report
Form 4
Stockwell Lynn
DirectorCEO and Exe. Chair of Board10% Owner
Transactions
- Purchase
Ordinary shares
2025-02-18+30,000→ 4,188,780 total(indirect: See Footnotes) - Purchase
Rights to receive ordinary shares
2025-02-18+30,000→ 430,000 total(indirect: See Footnotes)→ Ordinary shares (30,000 underlying)
Footnotes (2)
- [F1]Reflects the 30,000 private units acquired by Drugs Made In America Acquisition LLC, the Issuer's sponsor. Each private unit consists of one ordinary share and one right to receive one-eighth (1/8) of an ordinary share upon the consummation of an initial business combination. The private units were purchased at $10 per unit for an aggregate purchase price of $300,000. Lynn Stockwell is the managing member of the sponsor and has voting and dispositive power over the securities held of record by the sponsor. Ms. Stockwell disclaims any beneficial ownership of the securities held by the sponsor, except to the extent of her pecuniary interest therein.
- [F2]The rights convert automatically into ordinary shares at the completion of the Issuer's initial business combination.